Spun off from Novartis in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of ...

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S. market in the third quarter of 2025. International rollouts are expected to ...

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first ...

Nationwide recall affects five types of dry eye treatments due to manufacturing violations and sterility concerns.

Bausch + Lomb launched a preservative-free form of Lumify redness-reducing eye drops in the U.S., according to a press ...

According to the FDA, over 75,000 cases of five different eye drops and artificial tears were recalled. Here's what you need to know.

The eye drops are used to treat symptoms experienced by nearly 4 million Americans following an increasingly common procedure ...

AvKARE issued the voluntary recall for 1,819,080 cartons of eye drops in 75,795 cases. The Tennessee company said an audit by the Food and Drug Administration found manufacturing violations at BRS ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

Injection of an antibiotic and glucocorticoid after cataract surgery is far cheaper and as safe as a protocol 12 drops daily ...

Nearly 76,000 cases of eye care products – including eye drops sold nationwide – have been recalled by their manufacturer.